CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Conversion | +10,443 | 10,443 | ||
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Conversion | +4,747 | 15,190 | ||
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Conversion | +24,089 | 39,279 | ||
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Other acquisition | +2,377 | $6.79 | $16K | 41,656 |
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Conversion | +15,720 | 15,720 | ||
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Conversion | +21,221 | 36,941 | ||
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Purchase | +45,000 | $11.00 | $495K | 81,941 |
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Other acquisition | +1,651 | $7.75 | $13K | 83,592 |
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Conversion · Series B-1 Convertible Preferred Stock | −14,286 | 0 | ||
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Conversion · Series C Convertible Preferred Stock | −6,494 | 0 | ||
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Conversion · Series C-1 Convertible Preferred Stock | −32,956 | 0 | ||
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Conversion · Series C-1 Convertible Preferred Stock | −21,506 | 0 | ||
| 2015-10-06 | Einhorn Andrew J. Chief Financial Officer | Conversion · Series C-2 Convertible Preferred Stock | −29,032 | 0 | ||
| 2015-10-06 | Hove Anders D Director | Conversion | +1,571,917 | 1,571,917 | ||
| 2015-10-06 | Hove Anders D Director | Purchase | +450,000 | $11.00 | $5.0M | 2,021,917 |
| 2015-10-06 | Hove Anders D Director | Other acquisition | +46,665 | $8.60 | $401K | 2,068,582 |
| 2015-10-06 | Hove Anders D Director | Conversion · Series C-2 Convertible Preferred Stock | −2,150,538 | 0 | ||
| 2015-10-06 | Leuthner Brian A Chief Executive Officer | Conversion | +2,672 | 550,878 | ||
| 2015-10-06 | Leuthner Brian A Chief Executive Officer | Other acquisition | +80 | $8.60 | $688 | 550,958 |
| 2015-10-06 | Leuthner Brian A Chief Executive Officer | Conversion · Series C-2 Convertible Preferred Stock | −3,655 | 0 |
Page 17 of 18 · 346 trades